loadpatents
name:-0.0085551738739014
name:-0.006242036819458
name:-0.0021388530731201
Cervantes Guadarrama; Jorge Patent Filings

Cervantes Guadarrama; Jorge

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cervantes Guadarrama; Jorge.The latest application filed is for "methods of using a pharmaceutical composition containing pirfenidone in sustained-release tablet form".

Company Profile
1.6.7
  • Cervantes Guadarrama; Jorge - Mexico City MX
  • Cervantes Guadarrama; Jorge - Mexico MX
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods Of Using A Pharmaceutical Composition Containing Pirfenidone In Sustained-release Tablet Form
App 20210386724 - Armendariz Borunda; Juan Socorro ;   et al.
2021-12-16
Process for the preparation of a pharmaceutical composition containing pirfenidone in sustained-release tablet form and its application in the regression of human chronic renal failure, breast capsular contracture and hepatic fibrosis
Grant 11,052,074 - Armendariz Borunda , et al. July 6, 2
2021-07-06
Methods of using a pharmaceutical composition containing pirfenidone in sustained-release tablet form
Grant 11,040,030 - Armendariz Borunda , et al. June 22, 2
2021-06-22
Process For The Preparation Of A Pharmaceutical Composition Containing Pirfenidone In Sustained-release Tablet Form And Its Appl
App 20200038386 - Armendariz Borunda; Juan Socorro ;   et al.
2020-02-06
Methods Of Using A Pharmaceutical Composition Containing Pirfenidone In Sustained-release Tablet Form
App 20190358213 - ARMEND RIZ BORUNDA; Juan Socorro ;   et al.
2019-11-28
Methods of using a pharmaceutical composition containing pirfenidone in sustained-release tablet form
Grant 10,383,862 - Armendariz Borunda , et al. A
2019-08-20
Process for the preparation of a pharmaceutical composition containing pirfenidone in sustained-release tablet form and its application in the regression of human chronic renal failure, breast capsular contracture and hepatic fibrosis
Grant 9,962,374 - Armendariz Borunda , et al. May 8, 2
2018-05-08
Methods Of Using A Pharmaceutical Composition Containing Pirfenidone In Sustained-release Tablet Form
App 20180092893 - ARMEND RIZ BORUNDA; Juan Socorro ;   et al.
2018-04-05
Process For The Preparation Of A Pharmaceutical Composition Containing Pirfenidone In Sustained-release Tablet Form And Its Application In The Regression Of Human Chronic Renal Failure, Breast Capsular Contracture And Hepatic Fibrosis
App 20160287567 - ARMEND RIZ BORUNDA; Juan ;   et al.
2016-10-06
Pharmaceutical composition containing pirfenidone in sustained-release tablet form
Grant 9,408,836 - Armendariz Borunda , et al. August 9, 2
2016-08-09
Process For The Preparation Of A Pharmaceutical Composition Containing Pirfenidone In Sustained-release Tablet Form And Its Application In The Regression Of Human Chronic Renal Failure, Breast Capsular Contracture And Hepatic Fibrosis
App 20140296300 - Armendariz Borunda; Juan ;   et al.
2014-10-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed